Skip to Content
Merck

Skip To

CS0170

Thioredoxin Reductase Assay Kit

1 kit sufficient for 100 assays (1 mL)

Synonym(s):

Thioredoxin Reductase Activity Kit

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice
1 kit
Check Cart for Availability
CLP 797,000

About This Item

NACRES:
NA.84
UNSPSC Code:
12161503

CLP 797,000


Check Cart for Availability

Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

usage

 kit sufficient for 100 assays (1 mL)

shipped in

dry ice

storage temp.

−20°C

Gene Information

General description

The Thioredoxin Reductase Assay Kit uses a colorimetric assay for the determination of thioredoxin reductase activity in mammalian cells and tissues. It is based on the reduction of 5,5′-dithiobis(2-nitrobenzoic) acid (DTNB) with NADPH to 5-thio-2-nitrobenzoic acid (TNB) that produces a strong yellow color that is measured at 412 nm.

DTNB + NADPH + H+ ↔ 2 TNB + NADP+

Application

Using post nuclear extracts of rat liver, the kit shows linearity up to 0.25 units per mL. In this preparation, ~20% of the activity is due to non-specific reductase activity (refractory to the TrxR inhibitor).

Features and Benefits

  • An easy and simple method
  • The kit contains all the reagents required for a colorimetric assay of mammalian thioredoxin reductase
  • The kit includes an inhibitor solution for specific inhibition of mammalian thioredoxin reductase
  • The kit has been tested with heart muscle, as well as lysates from cell lines such as HeLa, A549, Jurkat, U937, A431, COS, CHO, and NIH 3T3 cells

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
CS1090CS0260CS0720
Gene Information

human ... TXNRD1(7296), TXNRD2(10587), TXNRD3(114112)

Gene Information

human ... HMGCR(3156)

Gene Information

human ... GSR(2936)

Gene Information

human ... CS(1431)

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

300

usage

 kit sufficient for 100 assays (1 mL)

usage

sufficient for 100 assays (200 μL), sufficient for 30 assays (1 mL)

usage

sufficient for 700 assays

usage

 kit sufficient for 100 reactions (using a 1 ml cuvette),  kit sufficient for 480 reactions (using 96 multiwell plates)

shipped in

dry ice

shipped in

dry ice

shipped in

wet ice

shipped in

dry ice

storage temp.

−20°C

storage temp.

−70°C

storage temp.

2-8°C

storage temp.

−20°C


Kit Components Only

Product No.
Description

  • Assay Buffer 5x for Thioredoxin Reductase 30 mL

  • Thioredoxin Reductase 10 μg

  • Thioredoxin Reductase Inhibitor Solution .05 mL

  • 5,5'-Dithiobis(2-nitrobenzoic) acid (DNTB) 150 mg

  • NADPH 25 mg

  • Dimethyl Sulfoxide (DMSO) 7.5 mL

signalword

Warning

Storage Class

10 - Combustible liquids

flash_point_f

188.6 °F

flash_point_c

87 °C

pictograms

Health hazardExclamation mark

Hazard Classifications

Eye Irrit. 2 - Repr. 2 - STOT SE 2

target_organs

Eyes,Central nervous system

wgk

WGK 3



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Matthew T Harper
Platelets, 30(1), 98-104 (2017-12-02)
Platelets are central to normal hemostasis and must be tightly controlled to prevent thrombosis. However, drug treatments that also affect platelets could lead to unwanted side effects on hemostasis or thrombosis. In this study, the effect of auranofin on platelets
Tessa D Epstein et al.
ACS infectious diseases, 5(10), 1682-1687 (2019-09-06)
Helicobacter pylori (H. pylori) infection poses a worldwide public health crisis, as chronic infection is rampant and can lead to gastric ulcers, gastritis, and gastric cancer. Unfortunately, frontline therapies cause harmful side effects and are often ineffective due to antibiotic resistance.
Melissa A Fath et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 17(19), 6206-6217 (2011-08-17)
Cancer cells (relative to normal cells) show increased steady-state levels of hydroperoxides that are compensated by increased glucose and hydroperoxide metabolism. The current study determined whether inhibitors of glucose and hydroperoxide metabolism could induce chemoradiosensitization by enhancing oxidative stress in



Global Trade Item Number

SKUGTIN
CS0170-1KT04061833553077

Questions

Reviews

No rating value

Active Filters